A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

Brief Summary

Type:
Cervical

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT07061977

Study #:
STUDY00162434

Start Date:
May 08, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT07061977

View Complete Trial Details & Eligibility at ClinicalTrials.gov